Showing results (21-30 of 536) with videos related to
Sort By:
Pageof 54
Biochemical Society Transactions|July 27, 2011
Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune diseaseLars Vereecke, Rudi Beyaert, Geert van LooTrends in Neurosciences|October 18, 2011
Death receptor signalling in central nervous system inflammation and demyelinationConor Mc Guire, Rudi Beyaert, Geert van LooEndocrine Reviews|April 14, 2007
Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyondAndy Wullaert, Geert van Loo, Karen Heyninck, et al.Trends in Immunology|November 20, 2013
A20 in inflammation and autoimmunityLeen Catrysse, Lars Vereecke, Rudi Beyaert, et al.International Review of Cytology|March 15, 2002
Signaling to gene activation and cell death by tumor necrosis factor receptors and FasRudi Beyaert, Geert Van Loo, Karen Heyninck, et al.Journal of Cell Science|January 20, 2005
Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitorsBart Depuydt, Geert van Loo, Peter Vandenabeele, et al.Trends in Immunology|April 4, 2020
A20 and Cell Death-driven InflammationDario Priem, Geert van Loo, Mathieu J M BertrandCell Death and Differentiation|September 26, 2024
NF-κB regulated expression of A20 controls IKK dependent repression of RIPK1 induced cell death in activated T cellsScott Layzell, Alessandro Barbarulo, Geert van Loo, et al.Circulation|September 1, 2012
Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of Toll-like receptor signaling in endothelial and myeloid cells in a mouse model of atherosclerosisApostolos Polykratis, Geert van Loo, Sofia Xanthoulea, et al.The Journal of Investigative Dermatology|February 19, 2017
S100B Is a Potential Disease Activity Marker in Nonsegmental VitiligoReinhart Speeckaert, Sofie Voet, Esther Hoste, et al.Pageof 54